131 related articles for article (PubMed ID: 28030426)
1. Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors.
Mahmoudpour SH; Veluchamy A; Siddiqui MK; Asselbergs FW; Souverein PC; de Keyser CE; Hofman A; Lang CC; Doney AS; Stricker BH; de Boer A; Maitland-van der Zee AH; Palmer CN;
Pharmacogenet Genomics; 2017 Mar; 27(3):112-119. PubMed ID: 28030426
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.
Mosley JD; Shaffer CM; Van Driest SL; Weeke PE; Wells QS; Karnes JH; Velez Edwards DR; Wei WQ; Teixeira PL; Bastarache L; Crawford DC; Li R; Manolio TA; Bottinger EP; McCarty CA; Linneman JG; Brilliant MH; Pacheco JA; Thompson W; Chisholm RL; Jarvik GP; Crosslin DR; Carrell DS; Baldwin E; Ralston J; Larson EB; Grafton J; Scrol A; Jouni H; Kullo IJ; Tromp G; Borthwick KM; Kuivaniemi H; Carey DJ; Ritchie MD; Bradford Y; Verma SS; Chute CG; Veluchamy A; Siddiqui MK; Palmer CN; Doney A; MahmoudPour SH; Maitland-van der Zee AH; Morris AD; Denny JC; Roden DM
Pharmacogenomics J; 2016 Jun; 16(3):231-7. PubMed ID: 26169577
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.
Hallberg P; Persson M; Axelsson T; Cavalli M; Norling P; Johansson HE; Yue QY; Magnusson PK; Wadelius C; Eriksson N; Wadelius M
Pharmacogenomics; 2017 Feb; 18(3):201-213. PubMed ID: 28084903
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit.
Morris AD; Boyle DI; McMahon AD; Pearce H; Evans JM; Newton RW; Jung RT; MacDonald TM
Diabetes Care; 1997 Sep; 20(9):1363-7. PubMed ID: 9283780
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
7. Replication and meta-analysis of previous genome-wide association studies confirm vezatin as the locus with the strongest evidence for association with endometriosis.
Pagliardini L; Gentilini D; Sanchez AM; Candiani M; Viganò P; Di Blasio AM
Hum Reprod; 2015 Apr; 30(4):987-93. PubMed ID: 25678572
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Coleman CI; Makanji S; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes.
Mas S; Gassò P; Alvarez S; Ortiz J; Sotoca JM; Francino A; Carne X; Lafuente A
Pharmacogenet Genomics; 2011 Sep; 21(9):531-8. PubMed ID: 21832968
[TBL] [Abstract][Full Text] [Related]
10. A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor.
Chung CM; Wang RY; Chen JW; Fann CS; Leu HB; Ho HY; Ting CT; Lin TH; Sheu SH; Tsai WC; Chen JH; Jong YS; Lin SJ; Chen YT; Pan WH
Pharmacogenomics J; 2010 Dec; 10(6):537-44. PubMed ID: 20066004
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough.
Mukae S; Itoh S; Aoki S; Iwata T; Nishio K; Sato R; Katagiri T
J Hum Hypertens; 2002 Dec; 16(12):857-63. PubMed ID: 12522467
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
Pathak JV; Dass EE
Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
[TBL] [Abstract][Full Text] [Related]
14. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci.
Ghouse J; Tragante V; Muhammad A; Ahlberg G; Skov MW; Roden DM; Jonsdottir I; Andreasen L; Lundegaard PR; Trudsø LC; Banasik K; Brunak S; Ostrowski SR; ; Torp-Pedersen C; Pedersen OV; Sørensen E; Køber L; Iversen K; Thorsteinsdottir U; Thorgeirsson G; Ullum H; Gudbjartsson DF; Mosley JD; Holm H; Stefansson K; Bundgaard H; Olesen MS
Eur Heart J; 2022 Dec; 43(45):4707-4718. PubMed ID: 35751511
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes.
van de Garde EM; Souverein PC; Hak E; Deneer VH; van den Bosch JM; Leufkens HG
J Hypertens; 2007 Jan; 25(1):235-9. PubMed ID: 17143196
[TBL] [Abstract][Full Text] [Related]
16. High order gene-gene interactions in eight single nucleotide polymorphisms of renin-angiotensin system genes for hypertension association study.
Yang CH; Lin YD; Wu SJ; Chuang LY; Chang HW
Biomed Res Int; 2015; 2015():454091. PubMed ID: 25961019
[TBL] [Abstract][Full Text] [Related]
17. ACE-inhibitor use and the long-term risk of renal failure in diabetes.
Suissa S; Hutchinson T; Brophy JM; Kezouh A
Kidney Int; 2006 Mar; 69(5):913-9. PubMed ID: 16518351
[TBL] [Abstract][Full Text] [Related]
18. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
Mathieson L; Severn A; Guthrie B
Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
[TBL] [Abstract][Full Text] [Related]
19. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
[TBL] [Abstract][Full Text] [Related]
20. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
